Marijuana: cardiovascular effects and legal considerations. A clinical case-based review.
| Autor: | Ahmad S; Cardiology Specialist Registrar Royal Lancaster Infirmary, Ashton Road, Lancaster, LA1 4RP., Hlaing SW; Trust Grade Doctor Royal Lancaster Infirmary, Ashton Road, Lancaster, LA1 4RP., Haris M; Internal Medical Trainee Royal Lancaster Infirmary, Ashton Road, Lancaster, LA1 4RP., Attar N; Consultant Cardiologist Royal Lancaster Infirmary, Ashton Road, Lancaster, LA1 4RP. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | The British journal of cardiology [Br J Cardiol] 2022 Apr 20; Vol. 29 (2), pp. 11. Date of Electronic Publication: 2022 Apr 20 (Print Publication: 2022). |
| DOI: | 10.5837/bjc.2022.011 |
| Abstrakt: | Though coronary artery disease primarily occurs in those over the age of 40 years, younger individuals who use recreational drugs may be afflicted with coronary events. Cannabis is one such perilous agent that can cause myocardial infarction (MI) and is one of the most common psychoactive drugs used worldwide. Cannabis (also known as marijuana, weed, pot, dope or grass) is the most widely used illegal drug in the UK. The desired euphoric effects are immediate, as are life-threatening hazardous ones. In this article, we briefly describe a case series of two unique but similar cases of cannabis-induced ST-elevation MI witnessed at our hospital in quick succession. We will analyse the composite pathophysiology in acute coronary syndromes provoked by cannabis and discuss the evolving legality around the use of the drug. Competing Interests: Conflicts of interest None declared. (Copyright © 2022 Medinews (Cardiology) Limited.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|